An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of ...
New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback